Northern Trust’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Northern Trust’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-17,332	Closed	-$8K	–	4302
2016 Q2	$8K	Hold	17,332	–	–	﹤0.01%	4172
2016 Q1	$46K	Hold	17,332	–	–	﹤0.01%	4038
2015 Q4	$53K	Hold	17,332	–	–	﹤0.01%	4043
2015 Q3	$76K	Buy	17,332 +1,036	+6%	+$6.09K	﹤0.01%	3999
2015 Q2	$93K	Sell	16,296 -3,238	-17%	-$22.1K	﹤0.01%	3966
2015 Q1	$174K	Buy	+19,534	New	+$157K	﹤0.01%	3907

Other funds holding EPRS

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Northern Trust's EPRS Position: Q3 2016 in Review

Northern Trust sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 17,332 shares — an estimated $8K sold.

Northern Trust first reported a position in EPRS in Q1 2015 and held it in 6 quarters. The position peaked at $174K in Q1 2015. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

Northern Trust reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
Northern Trust sold 17,332 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016, an estimated $8K.
Northern Trust first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q1 2015 and held it in 6 quarters.
Northern Trust's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $174K in Q1 2015.
3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on Northern Trust's 13F filing for Q3 2016, filed 10 Nov 2016.